Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Patients taking semaglutide had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease after three ...
Weight loss jabs cut the risk of heart death by a fifth, a study has found, with medics calling for them to be prescribed ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes ...